The RESHAPE-HF 2 trial studied Abbott’s heart clip device called the MitraClip, which is used to treat mitral regurgitation by preventing blood leakage into the heart chamber. The trial results, presented at the European Society of Cardiology meeting and published in the New England Journal of Medicine, showed that the device improved health status and reduced hospitalizations due to heart failure but did not reduce the number of deaths. The findings may lead to more debate among cardiologists regarding the efficacy of the device in treating patients with this condition.
Source link
Abbott’s MitraClip shows some benefit in heart failure patients
